4//SEC Filing
Asakowicz Steve 4
Accession 0001237648-18-000016
CIK 0001038133other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:22 PM ET
Size
9.9 KB
Accession
0001237648-18-000016
Insider Transaction Report
Form 4
HESKA CORPHSKA
Asakowicz Steve
EVP, Comp. Animal Health Sales
Transactions
- Award
Incentive Stock Option (right to buy)
2018-03-07+1,433→ 1,433 totalExercise: $69.77Exp: 2028-03-06→ Common Stock (1,433 underlying) - Award
Non-Qualified Stock Option (right to buy)
2018-03-07+8,567→ 8,567 totalExercise: $69.77Exp: 2028-03-06→ Common Stock (8,567 underlying) - Award
Performance Shares
2018-03-07+1,970→ 1,970 totalExp: 2025-03-31→ Common Stock (1,970 underlying)
Footnotes (2)
- [F1]The aggregate of these two option awards vests in three approximately equal annual installments beginning on March 7, 2019 and ending on March 7, 2021.
- [F2]The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the later of the achievement of $87.21 per share or the second anniversary of grant date. The second tranche is to vest at the later of the achievement of $101.17 per share or the third anniversary of grant date. The third tranche is to vest at the later of the achievement of $122.10 per share or the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.
Documents
Issuer
HESKA CORP
CIK 0001038133
Entity typeother
Related Parties
1- filerCIK 0001570456
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:22 PM ET
- Size
- 9.9 KB